This elevated risk is evident even after adjusting for the therapeutic interventions for COVID-19, such as systemic steroids and IL-6 inhibitors, and after accounting for the use of invasive procedures like central lines, mechanical ventilation, and ECMO using propensity score matching. The gene discussed is IL6; the disease is COVID-19.